Pharmacological conditioning as an add-on treatment for recent-onset rheumatoid arthritis
In this project we create an add-on treatment based on pharmacological conditioning, that can be used to boost the effectiveness of standard treatments for recent-onset rheumatoid arthritis.
Pharmacological conditioning with S-ketamine for widespread pain in patients with fibromyalgia syndrome
This project investigates whether pharmacological conditioning with S-ketamine is effective in reducing pain in patients with fibromyalgia.
Pharmacological conditioning of glucose and insulin in healthy individuals and patients with diabetes type 2
This project investigates whether pharmacological conditioning with insulin affects metabolic responses in healthy volunteers and patient with type-2 diabetes.
Placebo and nocebo effects in physical symptoms
Placebo and nocebo effect have been shown to affect a wide range of physical symptoms: pain, itch, breathlessness.
Placebo and nocebo effects in the brain
At IPS, we are dedicated to advancing the understanding of the brain mechanisms behind the placebo and nocebo effect.
Placebo and nocebo effects in the immune and endocrine system
Expectancies have been shown to affect not only self-reported outcomes, such as pain and itch, but also physiological markers such as endocrine and immune responses.
Placebo effects in children
Research is often done with adult volunteers. This is also true for research on how placebo and nocebo effects influence medical conditions and symptoms, and wellbeing.